Kawasumi Laboratories, Incorporated announced consolidated earnings results for the first quarter ended June 30, 2019. For the quarter, the company reported net sales of ¥5,721 million against ¥5,665 million a year ago. Operating profit was ¥343 million against loss of ¥30 million a year ago. Profit attributable to owners of parent was ¥175 million or ¥8.49 per share against ¥6 million or ¥0.31 per share a year ago. Profit was ¥174 million compared to ¥4 million a year ago.

The company provided consolidated earnings guidance for the year ending March 31, 2020. For the full year, the company expected net sales of ¥22,200 million, operating profit of ¥300 million, ordinary profit of ¥400 million and profit attributable to owners of parent of ¥300 million or ¥14.55 per share.

The company provided dividend guidance for the second quarter of fiscal 2020 and for the year ending March 31, 2020. For the second quarter of fiscal 2020, the company expects to pay dividend of ¥7.50 per share against a paid dividend of ¥7.50 per share for the same period a year ago.

For the year ending March 31, 2020, the company expected to pay dividend of ¥7.50 per share against ¥7.50.00 per share announced for the same period a year ago.